These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33209750)

  • 1. Patients' Attitudes, Awareness, and Opinions About Community Pharmacies in Japan: Next Steps for the Health Support Pharmacy System.
    Hirota N; Okamura N
    Integr Pharm Res Pract; 2020; 9():243-256. PubMed ID: 33209750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the association between the "My Pharmacist" model and the service quality of community pharmacies.
    Goto K; Sato T; Shikamura Y; Nomura K; Negishi K; Hanawa T
    Res Social Adm Pharm; 2020 Jul; 16(7):958-966. PubMed ID: 31839583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the factors influencing the quality of "Health Support Pharmacy" services in Japan: Perspectives of community pharmacists.
    Sato N; Fujita K; Kushida K; Chen TF
    Res Social Adm Pharm; 2020 Dec; 16(12):1686-1693. PubMed ID: 32147461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent community pharmacies' provision of enhanced services: A mixed methods approach.
    Facciolo F; Siracuse MV; Galt KA; Fuji KT; Bramble JD
    J Am Pharm Assoc (2003); 2021; 61(6):819-828.e1. PubMed ID: 34332888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provision of primary care to patients with chronic cough in the community pharmacy setting.
    Schneider CR; Everett AW; Geelhoed E; Kendall PA; Murray K; Garnett P; Salama M; Clifford RM
    Ann Pharmacother; 2011 Mar; 45(3):402-8. PubMed ID: 21325099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of patients' demand for community pharmacies: relationship between pharmacy services and patient satisfaction.
    Kamei M; Teshima K; Fukushima N; Nakamura T
    Yakugaku Zasshi; 2001 Mar; 121(3):215-20. PubMed ID: 11265116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public attitudes towards community pharmacy in Arabic speaking Middle Eastern countries: A systematic review.
    El Hajj MS; Mekkawi R; Elkaffash R; Saleh R; El Awaisi A; Wilbur K
    Res Social Adm Pharm; 2021 Aug; 17(8):1373-1395. PubMed ID: 33257161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community pharmacy practice in Japan--results of a survey.
    Iguchi S; Ohnishi M; Nishiyama T; Hosono K; Umezawa C
    J Clin Pharm Ther; 1998 Jun; 23(3):223-7. PubMed ID: 9831974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 15 Year Ecological Comparison for the Market Dynamics of Minnesota Community Pharmacies from 2002 to 2017.
    Olson AW; Schommer JC; Hadsall RS
    Pharmacy (Basel); 2018 Jun; 6(2):. PubMed ID: 29865252
    [No Abstract]   [Full Text] [Related]  

  • 10. Providing patient care through community pharmacies in the UK: policy, practice, and research.
    Noyce PR
    Ann Pharmacother; 2007 May; 41(5):861-8. PubMed ID: 17456540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing health literacy practices in a community pharmacy environment: experiences using the AHRQ Pharmacy Health Literacy Assessment Tool.
    O'Neal KS; Crosby KM; Miller MJ; Murray KA; Condren ME
    Res Social Adm Pharm; 2013; 9(5):564-96. PubMed ID: 23267822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ageing and the Case of Democratic Medicine in Japan.
    Hames A
    J Cross Cult Gerontol; 2020 Mar; 35(1):1-33. PubMed ID: 31782048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacy carer support service: obtaining new insight into carers in the community.
    McMillan SS; King MA; Stapleton H; Sav A; Kelly F; Wheeler AJ
    Int J Pharm Pract; 2019 Feb; 27(1):34-44. PubMed ID: 29732644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy.
    Brewer A; Hanna C; Eckmann L; Schadler A; Divine H
    J Am Pharm Assoc (2003); 2018; 58(4S):S69-S72.e1. PubMed ID: 30006188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.
    Gidman W; Coomber R
    Res Social Adm Pharm; 2014; 10(3):576-87. PubMed ID: 24021859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
    Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
    Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. College/school of pharmacy affiliation and community pharmacies' involvement in public health activities.
    Westrick SC; Mount J; Watcharadamrongkun S
    Am J Pharm Educ; 2009 Nov; 73(7):123. PubMed ID: 19960082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.